Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourExpanding
15 minExpanding
5 minConsolidating
Daily trend turns down below $2.90
Key levels
Resistance$5.68
Resistance$5.18
Support$4.58
Support$4.00
Latest news & SEC filings
No headlines in the last 90 days.
ENDRA Life Sciences develops and commercializes medical imaging technology for non-invasive assessment of liver health. Its main product is the TAEUS platform, which uses ultrasound-based thermography to measure fat in the liver. The company targets healthcare providers and clinicians, and operates in the United States and Europe.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
SEPT Low Target
$21.25
SEPT Mid Target
$25.00
SEPT High Target
$28.75
Analyst Consensus
$25.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NDRA.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$20.27
12
Moat Score
NONE
3/9
Piotroski Score
-43.2
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
84.32%
FCF Growth YoY
29.9%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for NDRA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 11:08:56 | $5.19 | 1,134 | $$6K | SELL |
| 17:21:45 | $4.35 | 4,000 | $$17K | BUY |
| 15:48:52 | $4.77 | 2,500 | $$12K | SELL |
| 20:38:51 | $4.96 | 1,000 | $$5K | BUY |
| 14:38:46 | $4.80 | 1,500 | $$7K | SELL |
5 dark pool trades shown · $$47K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for ENDRA Life Sciences Inc. (NDRA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ENDRA Life Sciences Inc. (NDRA) is at $4.73, down 0.84% (-$0.04) at the Nov 11, 2026 close.
The average analyst price target for NDRA is $25.00, ranging from $25 to $25, based on 1 analysts. Latest: Ascendiant Capital maintains on Jun 1, 2026.
Analyst ratings for NDRA: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
NDRA last reported on Aug 17, 2026: EPS $0.06 vs -$0.84 expected — a beat of 107.1%.
Yes. NDRA's dividend yield is 0.07%.
Support: $4.58, $4.00, $3.60. Resistance: $5.18, $5.68, $6.40.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.